Teladoc Health (TDOC)Bridgewater Associates reduced its stake -623K shares

12K

Shares reported · -623K vs prior quarter

0.00%

Disclosed portfolio weight

$64K

Reported value

Holdings as of

Mar 31, 2026

Filed

May 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 30, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Effective March 30, 2026, the Board of Directors (the “Board”) of Teladoc Health, Inc. (the “Company”) increased the number of directors on the Board to nine and appointed Susan R. Salka as a director of the Company.”
2. Apr 29, 2026Company filing · Form 8-K · ResultsReported its results

What came next

1. Jul 29, 2026Company filing · Form 8-K · ResultsReported its results
2. Aug 3, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Effective August 3, 2026, the Board of Directors (the “Board”) of Teladoc Health, Inc. (the “Company”) increased the number of directors on the Board to ten and appointed Mark V. Anquillare as a director of the Company.”
3. Aug 10, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 10, 2026, Mr. David B. Snow, Jr. notified Teladoc Health, Inc. (the “Company”) of his intention to retire from the Board effective as of September 30, 2026.”
4. Aug 27, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Effective August 31, 2026, Teladoc Health, Inc. (the “Company”) hired Michael Grasher as its Chief Financial Officer. Charles Divita, III, who served as the Company’s interim principal financial officer, will continue as Chief Executive Officer.”

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Teladoc Health

For Teladoc Health, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TDOC page.

How this filing works

• SEC Form 13F

Other disclosures at Teladoc Health

• SEC Form 4Oct 6, 2026
• SEC Form 13F-HRFeb 13, 2026
• SEC Form 13F-HRNov 14, 2025
• SEC Form 13F-HRNov 13, 2025
• SEC Form 4Sep 11, 2025
• SEC Form 4Sep 3, 2025

Everything OQRO holds on this company is on its TDOC page.